^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

BRL-301

i
Associations
Company:
BRL Medicine
Drug class:
CD19-targeted CAR-T immunotherapy
Related drugs:
Associations